Genus plc (GENSF)

Market Cap	2.25B
Revenue (ttm)	921.77M
Net Income (ttm)	26.44M
Shares Out	n/a
EPS (ttm)	0.40
PE Ratio	85.18
Forward PE	31.58
Dividend	0.41 (1.17%)
Ex-Dividend Date	Mar 6, 2025

Volume	100
Average Volume	1
Open	26.01
Previous Close	35.15
Day's Range	26.01 - 35.15
52-Week Range	20.51 - 35.15
Beta	0.62
RSI	98.94
Earnings Date	Nov 28, 2025

About Genus

Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1994
• Employees: 3,190
• Stock Exchange: OTCMKTS
• Ticker Symbol: GENSF

Financial Performance

In 2025, Genus's revenue was 672.80 million, an increase of 0.60% compared to the previous year's 668.80 million. Earnings were 19.30 million, an increase of 144.30%.

Financial numbers in GBP